{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02141542: Phase 1 Interventional Completed Metastatic Melanoma
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01405196: Phase 2 Interventional Completed Lupus Erythematosus, Systemic
(2011)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03299686: Phase 2 Interventional Completed Asthma
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03013998: Phase 1/Phase 2 Interventional Recruiting Previously Untreated Acute Myeloid Leukemia
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01566877: Phase 1 Interventional Completed Marburg Hemorrhagic Fever
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01775462: Phase 2 Interventional Completed X-Linked Hypohidrotic Ectodermal Dysplasia
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00082121: Phase 2 Interventional Completed Myocardial Ischemia
(2004)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02144051: Phase 1 Interventional Completed Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02624492: Phase 2 Interventional Completed Lymphoma, Large B-Cell, Diffuse
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02659631: Phase 1 Interventional Terminated Neoplasms
(2016)
Source URL:
Class:
CONCEPT